Berlin, Germany - Two separate groups of researchers have reported cases in which patients with recalcitrant adult-onset Still's disease (AOSD) showed a prompt response to treatment with the ...

Anakinra is not effective in reducing the need for mechanical ventilation among patients with severe COVID-19 pneumonia, according to a study published online April 7 in JAMA Network Open. Patricia ...

Anakinra is a recombinant human interleukin 1 antagonist, prescribed for reducing the pain and swelling associated with moderate to severe rheumatoid arthritis either alone or in combination with ...

The largest randomized controlled trial of patients with acute myocarditis has found that anakinra is safe but does not reduce complications. The late breaking research presented in a Hot Line session ...

Gout flare in the hand of an elderly person Researchers evaluated the efficacy and safety of anakinra for the treatment of acute gout flares. Undergoing 5 days of therapy with the IL-1 receptor ...

The anti-inflammatory biologic drug anakinra can safely and effectively treat the skin disorder hidradenitis suppurativa (HS), according to a small randomized controlled, double-blind trial published ...

Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) (SOBI.ST) today announced that the company has been granted a patent (EP2672985) in Europe for a new, citrate free formulation for Kineret® (anakinra).

Review the side-effects of Anakinra as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

The appraisal committee considered evidence submitted by Sobi, a review of this submission by the evidence review group (ERG), NICE's technical report and responses from stakeholders. See the ...

The interleukin (IL)-1 receptor antagonist anakinra (Kineret) was not superior to triamcinolone for relieving gout flares, but had similar effects for pain reduction as the glucocorticoid, a ...